IE43270B1 - Steroid compositions - Google Patents
Steroid compositionsInfo
- Publication number
- IE43270B1 IE43270B1 IE269/76A IE26976A IE43270B1 IE 43270 B1 IE43270 B1 IE 43270B1 IE 269/76 A IE269/76 A IE 269/76A IE 26976 A IE26976 A IE 26976A IE 43270 B1 IE43270 B1 IE 43270B1
- Authority
- IE
- Ireland
- Prior art keywords
- weight
- hydrocortisone
- composition
- propylene glycol
- composition according
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims description 38
- 150000003431 steroids Chemical class 0.000 title description 7
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 57
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 claims description 52
- 229960000890 hydrocortisone Drugs 0.000 claims description 26
- 230000000699 topical effect Effects 0.000 claims description 6
- 230000001804 emulsifying effect Effects 0.000 claims description 5
- 239000002674 ointment Substances 0.000 claims description 5
- 229920006395 saturated elastomer Polymers 0.000 claims description 5
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical group [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 3
- 239000004141 Sodium laurylsulphate Substances 0.000 claims description 3
- 125000000129 anionic group Chemical group 0.000 claims description 3
- 239000012188 paraffin wax Substances 0.000 claims description 3
- 235000019333 sodium laurylsulphate Nutrition 0.000 claims description 3
- 150000002191 fatty alcohols Chemical class 0.000 claims description 2
- 239000008194 pharmaceutical composition Substances 0.000 claims description 2
- 239000001993 wax Substances 0.000 claims description 2
- 229960004063 propylene glycol Drugs 0.000 claims 6
- 235000013772 propylene glycol Nutrition 0.000 claims 6
- 239000006185 dispersion Substances 0.000 claims 2
- 239000004094 surface-active agent Substances 0.000 claims 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 239000000243 solution Substances 0.000 description 6
- 230000000694 effects Effects 0.000 description 3
- QCDFBFJGMNKBDO-UHFFFAOYSA-N Clioquinol Chemical compound C1=CN=C2C(O)=C(I)C=C(Cl)C2=C1 QCDFBFJGMNKBDO-UHFFFAOYSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 229960005228 clioquinol Drugs 0.000 description 2
- 239000003246 corticosteroid Substances 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-L Phosphate ion(2-) Chemical compound OP([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-L 0.000 description 1
- 206010047139 Vasoconstriction Diseases 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
- 229960001347 fluocinolone acetonide Drugs 0.000 description 1
- FEBLZLNTKCEFIT-VSXGLTOVSA-N fluocinolone acetonide Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]2(C)C[C@@H]1O FEBLZLNTKCEFIT-VSXGLTOVSA-N 0.000 description 1
- -1 fluoeinonide Chemical class 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 230000025033 vasoconstriction Effects 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Endocrinology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB7030/75A GB1543907A (en) | 1975-02-19 | 1975-02-19 | Steroid compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE43270L IE43270L (en) | 1976-08-19 |
| IE43270B1 true IE43270B1 (en) | 1981-01-28 |
Family
ID=9825303
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE269/76A IE43270B1 (en) | 1975-02-19 | 1976-02-11 | Steroid compositions |
Country Status (7)
| Country | Link |
|---|---|
| JP (1) | JPS609486B2 (enrdf_load_stackoverflow) |
| AU (1) | AU502937B2 (enrdf_load_stackoverflow) |
| DE (1) | DE2606516A1 (enrdf_load_stackoverflow) |
| FR (1) | FR2341317A1 (enrdf_load_stackoverflow) |
| GB (1) | GB1543907A (enrdf_load_stackoverflow) |
| IE (1) | IE43270B1 (enrdf_load_stackoverflow) |
| ZA (1) | ZA76980B (enrdf_load_stackoverflow) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR830005852A (ko) * | 1980-07-18 | 1983-09-14 | 미첼 페터 잭슨 | 피부와 점막의 비루스 감염치료에 적합한 국소치료제의 제조방법 |
| GB2080106B (en) * | 1980-07-18 | 1984-03-07 | Weelcome Foundation Ltd | Acyclovin preparations |
| JPS59137408A (ja) * | 1983-01-27 | 1984-08-07 | Taisho Pharmaceut Co Ltd | 軟膏 |
| AT389447B (de) * | 1983-01-27 | 1989-12-11 | Taisho Pharmaceutical Co Ltd | Verfahren zur herstellung einer topischen steroidsalbe |
| JPS59139315A (ja) * | 1983-01-31 | 1984-08-10 | Taisho Pharmaceut Co Ltd | クリ−ム剤 |
| WO1996020712A1 (en) * | 1994-12-30 | 1996-07-11 | American Home Products Corporation | Clear non-alcoholic hydrocortisone solutions |
| GB2302808A (en) * | 1995-07-04 | 1997-02-05 | Surtech Int Ltd | Propylene glycol with low potency corticosteroids for topical treatment of the scalp |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA725898B (en) * | 1972-05-30 | 1973-05-30 | Sackler R | Iodophor steroid pharmaceutical compositions |
| US3892857A (en) * | 1972-11-24 | 1975-07-01 | Squibb & Sons Inc | Steroid formulation |
-
1975
- 1975-02-19 GB GB7030/75A patent/GB1543907A/en not_active Expired
-
1976
- 1976-02-11 IE IE269/76A patent/IE43270B1/en unknown
- 1976-02-18 FR FR7604443A patent/FR2341317A1/fr active Granted
- 1976-02-18 DE DE19762606516 patent/DE2606516A1/de active Granted
- 1976-02-18 ZA ZA980A patent/ZA76980B/xx unknown
- 1976-02-18 JP JP51016083A patent/JPS609486B2/ja not_active Expired
- 1976-02-19 AU AU11232/76A patent/AU502937B2/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| GB1543907A (en) | 1979-04-11 |
| ZA76980B (en) | 1977-01-26 |
| AU1123276A (en) | 1977-08-25 |
| IE43270L (en) | 1976-08-19 |
| DE2606516C2 (enrdf_load_stackoverflow) | 1987-09-17 |
| AU502937B2 (en) | 1979-08-16 |
| FR2341317A1 (fr) | 1977-09-16 |
| FR2341317B1 (enrdf_load_stackoverflow) | 1979-06-08 |
| JPS609486B2 (ja) | 1985-03-11 |
| JPS51106713A (enrdf_load_stackoverflow) | 1976-09-21 |
| DE2606516A1 (de) | 1976-09-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4170637A (en) | Frosting bleach composition | |
| US4794106A (en) | Cream | |
| US4082881A (en) | Topical and other type pharmaceutical formulations containing isosorbide carrier | |
| EP0727979B1 (en) | Novel composition | |
| US4289764A (en) | Steroid compositions | |
| US4008321A (en) | Composition for a topical preparation and a process for producing the same | |
| US4048310A (en) | Topical steroid formulation in form of lotion or cream | |
| JPS6281318A (ja) | ハイドロコ−チゾンジエステルを含有するクリ−ム | |
| CA1182048A (en) | Topically administrable pharmaceutical compositions containing anti-inflammatory steroids | |
| JPH0784382B2 (ja) | 医薬組成物 | |
| EP0020117A2 (en) | Corticosteroid formulations containing sebacate carrier | |
| IE43270B1 (en) | Steroid compositions | |
| US4436738A (en) | Stabilized estradiol cream composition | |
| JPS58225009A (ja) | コルチコステロイド外用製剤 | |
| CA1266614A (en) | W/o cream containing hydrocortisone diester | |
| Coldman et al. | The evaluation of several topical corticosteroid preparations in the blanching test | |
| GB2443162A (en) | Spray foaming dosage form comprising betamethasone valerate | |
| CA2376850C (en) | Topical formulations comprising skin penetration agents and the use thereof | |
| US4794107A (en) | Ointment | |
| US4299828A (en) | Corticosteroid stick formulations | |
| US4048309A (en) | Topical steroid ointment formulations | |
| US20090298803A1 (en) | Pharmaceutical composition comprising fluocinonide | |
| CA1040534A (en) | Stabilized steroid formulations | |
| US4279901A (en) | Topical ointment | |
| JPH05505405A (ja) | アメトカインを含有する医薬組成物 |